152 related articles for article (PubMed ID: 35286052)
1. Subcutaneous adipose tissue is a positive predictor for bone mineral density in prepubertal children with Prader-Willi syndrome independent of lean mass.
Kawai M; Etani Y; Ida S
J Pediatr Endocrinol Metab; 2022 May; 35(5):603-609. PubMed ID: 35286052
[TBL] [Abstract][Full Text] [Related]
2. Relative Contributions of Lean and Fat Mass to Bone Mineral Density: Insight From Prader-Willi Syndrome.
Viardot A; Purtell L; Nguyen TV; Campbell LV
Front Endocrinol (Lausanne); 2018; 9():480. PubMed ID: 30186239
[No Abstract] [Full Text] [Related]
3. Visceral adipose tissue increases shortly after the cessation of GH therapy in adults with Prader-Willi syndrome.
Koizumi M; Ida S; Shoji Y; Nishimoto Y; Etani Y; Kawai M
Endocr J; 2018 Nov; 65(11):1127-1137. PubMed ID: 30185718
[TBL] [Abstract][Full Text] [Related]
4. Bone mineral density and effects of growth hormone treatment in prepubertal children with Prader-Willi syndrome: a randomized controlled trial.
de Lind van Wijngaarden RF; Festen DA; Otten BJ; van Mil EG; Rotteveel J; Odink RJ; van Leeuwen M; Haring DA; Bocca G; Mieke Houdijk EC; Hokken-Koelega AC
J Clin Endocrinol Metab; 2009 Oct; 94(10):3763-71. PubMed ID: 19622627
[TBL] [Abstract][Full Text] [Related]
5. Bone mineral density in children and adolescents with Prader-Willi syndrome: a longitudinal study during puberty and 9 years of growth hormone treatment.
Bakker NE; Kuppens RJ; Siemensma EP; Tummers-de Lind van Wijngaarden RF; Festen DA; Bindels-de Heus GC; Bocca G; Haring DA; Hoorweg-Nijman JJ; Houdijk EC; Jira PE; Lunshof L; Odink RJ; Oostdijk W; Rotteveel J; Van Alfen AA; Van Leeuwen M; Van Wieringen H; Wegdam-den Boer ME; Zwaveling-Soonawala N; Hokken-Koelega AC
J Clin Endocrinol Metab; 2015 Apr; 100(4):1609-18. PubMed ID: 25668198
[TBL] [Abstract][Full Text] [Related]
6. Update on body composition and bone density in children with Prader-Willi syndrome.
Rubin DA; Cano-Sokoloff N; Castner DL; Judelson DA; Wright P; Duran A; Haqq AM
Horm Res Paediatr; 2013; 79(5):271-6. PubMed ID: 23615452
[TBL] [Abstract][Full Text] [Related]
7. Body fat mass, lean body mass and associated biomarkers as determinants of bone mineral density in children 6-8years of age - The Physical Activity and Nutrition in Children (PANIC) study.
Soininen S; Sidoroff V; Lindi V; Mahonen A; Kröger L; Kröger H; Jääskeläinen J; Atalay M; Laaksonen DE; Laitinen T; Lakka TA
Bone; 2018 Mar; 108():106-114. PubMed ID: 29307776
[TBL] [Abstract][Full Text] [Related]
8. Characterization of fat distribution in Prader-Willi syndrome: relationships with adipocytokines and influence of growth hormone treatment.
Tanaka Y; Abe Y; Oto Y; Itabashi H; Shiraishi M; Yoshino A; Obata K; Murakami N; Nagai T
Am J Med Genet A; 2013 Jan; 161A(1):27-33. PubMed ID: 23239671
[TBL] [Abstract][Full Text] [Related]
9. Sustained benefits of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome are dose-dependent.
Carrel AL; Myers SE; Whitman BY; Allen DB
J Pediatr Endocrinol Metab; 2001; 14(8):1097-105. PubMed ID: 11592566
[TBL] [Abstract][Full Text] [Related]
10. Body compositions differently contribute to BMD in different age and gender: a pilot study by QCT.
Zhang X; Hua T; Zhu J; Peng K; Yang J; Kang S; Xu T; Hu J; Tang G
Arch Osteoporos; 2019 Mar; 14(1):31. PubMed ID: 30847583
[TBL] [Abstract][Full Text] [Related]
11. Visceral fat is a negative predictor of bone density measures in obese adolescent girls.
Russell M; Mendes N; Miller KK; Rosen CJ; Lee H; Klibanski A; Misra M
J Clin Endocrinol Metab; 2010 Mar; 95(3):1247-55. PubMed ID: 20080853
[TBL] [Abstract][Full Text] [Related]
12. Associations of Fat Mass and Fat Distribution With Bone Mineral Density in Non-Obese Postmenopausal Chinese Women Over 60 Years Old.
Fan J; Jiang Y; Qiang J; Han B; Zhang Q
Front Endocrinol (Lausanne); 2022; 13():829867. PubMed ID: 35145487
[TBL] [Abstract][Full Text] [Related]
13. Peculiar body composition in patients with Prader-Labhart-Willi syndrome.
Brambilla P; Bosio L; Manzoni P; Pietrobelli A; Beccaria L; Chiumello G
Am J Clin Nutr; 1997 May; 65(5):1369-74. PubMed ID: 9129464
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone treatment and bone mineral density in pediatric patients with Prader-Willi syndrome.
Oto Y; Murakami N; Inoue T; Matsubara K; Saima S; Ogata H; Ihara H; Nagai T; Matsubara T
J Pediatr Endocrinol Metab; 2021 Sep; 34(9):1181-1184. PubMed ID: 34162033
[TBL] [Abstract][Full Text] [Related]
15. Anthropometric adjustments are helpful in the interpretation of BMD and BMC Z-scores of pediatric patients with Prader-Willi syndrome.
Hangartner TN; Short DF; Eldar-Geva T; Hirsch HJ; Tiomkin M; Zimran A; Gross-Tsur V
Osteoporos Int; 2016 Dec; 27(12):3457-3464. PubMed ID: 27377921
[TBL] [Abstract][Full Text] [Related]
16. Bone mineral density in young adults with Prader-Willi syndrome: A randomized, placebo-controlled, crossover GH trial.
Donze SH; Kuppens RJ; Bakker NE; van Alfen-van der Velden JAEM; Hokken-Koelega ACS
Clin Endocrinol (Oxf); 2018 Jun; 88(6):806-812. PubMed ID: 29418016
[TBL] [Abstract][Full Text] [Related]
17. Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome.
Myers SE; Carrel AL; Whitman BY; Allen DB
J Pediatr; 2000 Jul; 137(1):42-9. PubMed ID: 10891820
[TBL] [Abstract][Full Text] [Related]
18. Body composition during GH treatment in Prader-Labhardt-Willi syndrome.
Bosio L; Beccaria L; Benzi F; Sanzari A; Chiumello G
J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():351-3. PubMed ID: 10698601
[TBL] [Abstract][Full Text] [Related]
19. Associations of fat mass and fat distribution with bone mineral density in Chinese obese population.
Zhang J; Jin Y; Xu S; Zheng J; Zhang Q; Chen J; Huang Y; Shao H; Yang D; Ying Q
J Clin Densitom; 2015; 18(1):44-9. PubMed ID: 24815308
[TBL] [Abstract][Full Text] [Related]
20. Two years of growth hormone treatment in adults with Prader-Willi syndrome do not improve the low BMD.
Jørgensen AP; Ueland T; Sode-Carlsen R; Schreiner T; Rabben KF; Farholt S; Høybye C; Christiansen JS; Bollerslev J
J Clin Endocrinol Metab; 2013 Apr; 98(4):E753-60. PubMed ID: 23436915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
